Krystal Biotech Inc. (KRYS)
181.44
6.86 (3.93%)
At close: Apr 02, 2025, 3:59 PM
181.00
-0.24%
After-hours: Apr 02, 2025, 04:05 PM EDT
Krystal Biotech Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 344.87M | 358.33M | 161.9M | 341.25M | 268.27M | 187.51M | 103.67M | 49.59M | 1.92M |
| Short-Term Investments | 252.65M | 173.85M | 217.27M | 96.85M | 2.99M | 6.17M | 8.09M | n/a | n/a |
| Long-Term Investments | 152.11M | 61.95M | 4.62M | 64.37M | n/a | 497K | n/a | n/a | n/a |
| Other Long-Term Assets | 231K | 263K | 324K | 74K | 1.61M | 1.46M | 452K | n/a | n/a |
| Receivables | 104.75M | 42.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | 26.51M | 6.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 13.27M | 6.71M | 4.61M | 4.17M | 3.8M | 2.19M | 889K | n/a | n/a |
| Total Current Assets | 742.04M | 587.91M | 383.78M | 442.27M | 275.06M | 195.88M | 112.65M | 49.91M | 2.17M |
| Property-Plant & Equipment | 161.45M | 168.23M | 169.73M | 119.58M | 34.17M | 11.18M | 3.01M | 200K | 13K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 313.79M | 230.45M | 174.67M | 184.03M | 35.79M | 13.14M | 3.47M | 200K | 13K |
| Total Assets | 1.06B | 818.36M | 558.45M | 626.29M | 310.84M | 209.02M | 116.12M | 50.11M | 2.18M |
| Account Payables | 4.99M | 1.85M | 3.98M | 8.4M | 2.1M | 724K | 888K | 193K | 42K |
| Deferred Revenue | n/a | n/a | n/a | 16.21M | 5.08M | 2.1M | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | 1.56M | n/a | 8.24M | 480K | n/a | n/a | n/a |
| Other Current Liabilities | 2.4M | 16.75M | 14.92M | 13.41M | -4.66M | 1.13M | 1.36M | 437K | n/a |
| Total Current Liabilities | 102M | 33.09M | 28.85M | 25.74M | 15.45M | 3.33M | 2.6M | 640K | 43K |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.84M |
| Other Long-Term Liabilities | 1.42M | n/a | n/a | n/a | n/a | n/a | 294K | n/a | 7K |
| Total Long-Term Liabilities | 7.46M | 6.62M | 7.37M | 6.98M | 3.31M | 2.78M | 294K | n/a | 1.85M |
| Total Liabilities | 109.46M | 39.71M | 36.22M | 32.72M | 18.76M | 6.11M | 2.89M | 640K | 1.89M |
| Total Debt | 7.26M | 8.09M | 8.93M | 8.02M | 11.55M | 3.26M | n/a | n/a | 1.84M |
| Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -180.67M | -269.83M | -280.76M | -140.78M | -71.21M | -39.05M | -19.96M | -9.07M | -1.15M |
| Comprehensive Income | -190K | 638K | -728K | -163K | 6K | 10K | 2K | -25K | -2K |
| Shareholders Equity | 946.38M | 778.64M | 522.23M | 593.58M | 292.08M | 202.91M | 113.23M | 49.47M | 289K |
| Total Investments | 404.77M | 235.8M | 221.89M | 161.22M | 2.99M | 6.67M | 8.09M | n/a | n/a |